Several DNA vaccines are currently in clinical trials which are expected to get approval soon. The industry has garnered interest of investors with funds pouring in from industry over and above development funding provided by government. Rise in R&D activities in the industry is anticipated to propel growth of the market.
The report ?Global DNA Vaccine Market Outlook 2025? provides in-depth analysis of the current scenario, detailed market outlook of the global DNA vaccine market overall as well as across various geographies. Regional analysis is done across major markets in North America, Europe and Asia Pacific.
The report provides comprehensive coverage on major industry drivers, restraints, and their impact on market growth during the forecast period. Furthermore, the study encompasses various market specific growth opportunities in global DNA vaccine market. The report has been segmented as following:-
Geographical Coverage
? North America
? Europe
? Asia Pacific
Key Vendors
? Novartis International AG
? Merck & Co. Inc.
? GlaxoSmithKline plc
? Sanofi Pasteur SA
? Pfizer Inc.
? Astellas Pharma
? Dendreon Corporation

DNA vaccines are third generation vaccines that has revolutionized the world of immunization. DNA vaccines are bacterial plasmids that contains genetic material of disease-causing pathogen which are injected to provide protection against array of diseases. These transgenes which are capable of encoding antigenic proteins, triggers an immune response against the infectious diseases. The technology has an edge over conventional vaccinations with respect to safety aspect, efficacy, action mechanism, ease of storage and manufacturing. However, till date only few DNA vaccines have gained approval that too for animal use. There are large number of DNA vaccine for human use in clinical trial.
Global DNA vaccine market is poised to grow at staggering growth rates. Growth of the market is attributed to higher incidences of infectious diseases, increasing adoption in animal healthcare, growing demand for novel vaccines and advantages over conventional vaccines. However, the faces several challenges due to various factors such as ambiguous regulatory system, less market penetration especially in emerging nations and incompatibility of DNA vaccine with other vaccines.
The report ?Global DNA Vaccine Market Outlook 2025? provides in-depth analysis of the current scenario, detailed market outlook of the global DNA vaccine market with market segmentation done across major geographies such as North America, Europe and Asia Pacific. Future forecasts of DNA vaccine market overall and across various regional markets has been provided in the report till 2025. Furthermore, major industry players have been prudently analyzed in the competitive landscape section of the report in order to provide key comparative insights.
Major industry players operating in the global DNA vaccine market include Novartis International AG, Merck & Co. Inc., GlaxoSmithKline plc, Sanofi Pasteur SA, Pfizer Inc., Astellas Pharma, Dendreon Corporation, among others. These players are profiled herein based on attributes such as business overview, product segments and financial analysis. It also compiles performance comparison of aforementioned companies and other leading companies in the segment based on various parameters in the competitive landscape section. In totality, the report provides detailed market analysis, with relevant forecasted data supported by key market dynamics. This information will be helpful in evaluating opportunities in global DNA vaccine market.